Easy and Secure Rapid Microbial Detection

The Celsis Advance II™ ATP Luminometer Platform delivers results in just 24-36 hours for microbial limits (USP <61>) quality control testing and 6 days for sterility testing (USP <71>), allowing you to rapidly confirm the quality of your products and quickly release them to market. 

ACCELERATE YOUR TESTING 

The ability of this rapid microbial detection system to confidently confirm the absence of contamination allows your in-house quality system to: 

  • Shorten production cycle times
  • Decrease working capital requirements as well as safety stock
  • Reduce inventory requirements and warehouse space costs
  • Receive earlier notification in the event of a contamination
  • Respond to contamination and conduct investigations faster 
MS_2025_Celsis_Brochure_Banners-&-Images-for-Promotion_400x268.png

Explore the Celsis® Rapid Microbial Detection Brochure
Gain insight into Celsis® technologies, platform capabilities, implementation considerations, validation support, and microbial detection applications across a range of product types.
Access the Brochure

Introducing Celsis Advance II™ ATP Luminometer Platform

  • Celsis Advance II™ ATP Luminometer Platform Features
    • Runs up to 120 assays per hour with the option of combining multiple batches or protocols into a single run
    • Developed exclusively for large scale pharmaceutical and home and personal care manufacturing
    • Offline incubation maximizes system throughput
    • Click to start: enjoy walk-away automation
    • Compact, bench-top instrument 
  • Advance.im Software Features
    • A new, secure ‘Remote User Option’ allows monitoring of product quality testing results from multiple locations, facilitating global data integrity harmonization initiatives
    • Automated data capture and storage, exporting to common database programs, including Excel and Access
    • Design and generate graphs for easy data trending and report generation
    • Customizable security levels with one-click lockout
    • Fully validated on Microsoft Windows® operating systems
    • Allows full compliance with the FDA’s 21 CFR Part 11 and the European Union’s Annex 11 recommendations for data integrity best practices 
  • Specifications
    • Compact footprint:
      • 28.5” x 15.8” x 17” (w x h x d)
      • 65.6 cm x 40.1 cm x 43.3 cm (w x h x d)
      • Weight: 62 lbs / 28 kg
    • Electrical Requirements: 100 -240 Volts, 50 or 60 Hz
    • Optional Fourth Injector
    • Validated on Microsoft Windows® XP Professional, Windows® 7 Professional, Windows® 8 Pro, and Windows 10 
ProductCode
Celsis Advance II™ SystemC7456004

Get Full Product Details

How the Celsis Advance II™ ATP Luminometer Platform Works 

The Celsis® assay rapidly confirms the presence or absence of microbial contamination using an amplified ATP-based bioluminescence reaction. Our method preserves your originally validated sample preparation methods, such as bioburden filtration or direct inoculation. Once prepared, the samples are enriched for a period based on your product specification. Upon completion, samples require minimal steps before being loaded into the Celsis Advance II™ ATP Luminometer Platform. Up to four variable-volume reagent injectors ensure accuracy, reduce sample handling, and increase flexibility. System throughput runs as high as 120 tests per hour with the option of simultaneously combining multiple batches or protocols into a single run. The user interface of the LIMS-compatible system software objectively interprets and displays results in a color-coded table or graphical view.

REQUEST PRICING 

Guidance on Implementation of Alternative and RMMs Ebook cover

Guidance on Implementation of Alternative RMMs 
This Ebook addresses the technical, business, and data integrity issues in implementing ARMM technologies for the development, in-process control, and commercial release of drug products.
Access the Ebook


Frequently Asked Questions (FAQs) About Data Integrity for ATP Luminometer Platforms

  • What is a luminometer?

    The Celsis Advance II™ ATP Luminometer Platform rapidly confirms and measures the presence or absence of microbial contamination using an amplified ATP-based bioluminescence reaction. 

  • What is data integrity in microbiology quality control?

    Data integrity is a collection of practices that lead to secure reporting, handling, and archiving of quality control testing data generated in the microbiology lab. Data integrity allows laboratories to make sound decisions based on their test data and have confidence that the data is not inadvertently or intentionally manipulated.

  • How do instruments like the Celsis Advance II™ ATP Luminometer Platform help with data integrity?

    Instruments like the Celsis Advance II and Celsis Accel® lead to better data integrity practices in two ways: by replacing subjective tests involving visual, human-based confirmation of no growth with an automated assay, and by handling the reporting of results via software.

  • What’s the risk of using subjective test methods with data integrity?

    With subjective tests such as visual turbidity or visual enumeration of plates that are typically 0 CFU (such as Water for Injection), there is a risk of missing a positive count. In certain production processes, contaminations are so infrequent that analysts do not have experience ever seeing a certain sample come back positive, or maybe become accustomed to samples never being contaminated. Additionally, when transcribing and reporting results, analysts can make transcription errors due to handwriting or mistaken keystrokes. 

vial and syringe

Let Us Perform Your RMM Validation
We can perform the necessary validation testing to meet criteria set forth in USP <1223> and Ph. Eur. <5.1.6> on your behalf. Learn how we can reduce your timeline to implementation by more than half with our Celsis® Complete or our Celsis® Advantage packages.
Fast Track Your RMM Validation